Skape Bio Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.3M
- Investors
-
5
Skape Bio General Information
Description
Developer of a drug discovery platform designed for pharmaceutical companies to unlock G protein-coupled receptors. The company's AI-driven platform unites generative protein design, native receptor biology and scalable in-cell screening, enabling drug developers to access unreachable therapeutic targets and achieve precise receptor modulation.
Contact Information
Website
www.skape.bioCorporate Office
- C/O BioInnovation Institute
- Ole Maaløes Vej 3
- 2200 Copenhagen
- Denmark
Corporate Office
- C/O BioInnovation Institute
- Ole Maaløes Vej 3
- 2200 Copenhagen
- Denmark
Skape Bio Timeline
Skape Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 27-Nov-2025 | $1.3M | Completed | Startup | ||
| 4. Early Stage VC | 19-Jun-2025 | Completed | Startup | |||
| 3. Accelerator/Incubator | 31-Mar-2026 | Completed | ||||
| 2. Accelerator/Incubator | $3.13M | $3.13M | Completed | |||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Skape Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Skape Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Skape Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UW CoMotion | Accelerator/Incubator | |||
| Pack Ventures | Venture Capital | Minority | ||
| Sahsen Ventures | Venture Capital | Minority | ||
| BioInnovation Institute | Accelerator/Incubator | |||
| Mission BioCapital | Venture Capital | Minority |
Skape Bio FAQs
-
When was Skape Bio founded?
Skape Bio was founded in 2025.
-
Where is Skape Bio headquartered?
Skape Bio is headquartered in Copenhagen, Denmark.
-
What is the size of Skape Bio?
Skape Bio has 13 total employees.
-
What industry is Skape Bio in?
Skape Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Skape Bio a private or public company?
Skape Bio is a Private company.
-
What is Skape Bio’s current revenue?
The current revenue for Skape Bio is .
-
How much funding has Skape Bio raised over time?
Skape Bio has raised $6.92M.
-
Who are Skape Bio’s investors?
UW CoMotion, Pack Ventures, Sahsen Ventures, BioInnovation Institute, and Mission BioCapital have invested in Skape Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
